Prevalence of Peripheral Arterial Disease in Patients with Acute Coronary Síndrome (PAMISCA) Investigators. Prevalence and prognostic influence of peripheral arterial disease in patients > or = 40 years old admitted into hospital following an acute coronary event Bertomeu V, Morillas P, González-Juanatey JR, Quiles J, Guindo J, Soria F, Llacer A, Lekuona I, Mazón P, Martín-Luengo C, Rodríguez-Padial L. European Journal of Vascular and 36(2):189-96. FI: 2.919 (Q2) The scope of cardiological competence in the new clinical settings. Spanish Society of Cardiology consensus document Escaned Barbosa J, Roig Minguell E, Chorro Gascó FJ, De Teresa Galván E, Jiménez Mena M, López de Sá y Areses E, Alfonso Manterola F, Gómez Esmorís L, Martin Burrieza F, Salvador Taboada MJ, Alonso-Pulpón Rivera LA. Comité de Expertos del Proyecto Futuro de la Cardiología, Anguita Sánchez M, Asín Cardiel E, Bosch Genover X, Castro Beiras A, Cañadas Godoy V, Fernández Avilés F, García Pavía P, Lidón Corbí RM, López Sendón JL, Macaya Miguel C, Masía Martorel R, Murga Eizagaechevarría N, Ortega Marcos J, Permanyer Miralda C, Sales González E, Sanchis Fores J, Sanz Romero G, Tornos Mas P. Sociedad Española de Cardiología. Revista Española de Cardiología 61(2):161-9. FI: 2.746 (Q2) Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome Kaski JC, Consuegra-Sanchez L, Fernandez-Berges DJ, Cruz-Fernandez JM, Garcia-Moll X, Marrugat J, Mostaza J, Toro-Cebada R, González-Juanatey JR, Guzmán-Martínez G. SIESTA Investigators. Atherosclerosis 201(1):176-83. FI: 4.522 (Q1) Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification Bratos-Pérez MA, Sánchez PL, García de Cruz S, Villacorta E, Palacios IF, Fernández-Fernández JM, Di Stefano S, Orduña-Domingo A, Carrascal Y, Mota P, Martín-Luengo C, Bermejo J, San Roman JA, Rodríguez-Torres A, Fernández-Avilés F. Grupo AORTICA (Grupo de Estudio de la Estenosis Aórtica). European Heart Journal 29(3):371-6. FI: 9.800 (Q1) Relationship between QRS duration and prognosis in non-ST-segment elevation acute coronary syndrome Jiménez-Candil J, Cruz González I, Martín F, Pabón P, León V, Hernández J, Sánchez-Flores M, Moríñigo J, Ledesma C, Martín-Luengo C. International Journal of Cardiology 126(2):196-203. FI: 3.469 (Q2) Relationship between the QTc interval at hospital admission and the severity of the underlying ischaemia in low and intermediate risk people studied for acute chest pain Jiménez-Candil J, Diego M, Cruz González I, González MataJM, Martín F, Pabón P, Ramírez V, León V, Martín-Luengo C. International Journal of Cardiology 126(1):84-91. FI: 3.469 (Q2) Foramen oval permeable: situación actual Cruz-Gonzalez I, Solis J, Inglessis-Azuaje I, Palacios IF. Revista Española de Cardiología 61(7):738-51. FI: 2.746 (Q2). Impact of concomitant aortic regurgitation on percutaneous mitral valvuloplasty: immediate results, short ¿and long-term outcomes Cruz-González I, Sanchez Ledesma M, Sanchez PL, Martín-Moreiras J, Jneid H, Renfigo-Moreno P, Cubeddu RJ, Inglessis I, Maree AO, Palacios IF. American Heart Journal 156(2):361-6. FI: 4.357 (Q1) Efficacy and safety of argatroban in patients with heparin induced trombocitopenia undergoing endovascular intervention for peripheral arterial disease Baron SJ, Yeh RW, Cruz-González I, Healy JL, Pomerantsev E, Garasic J, Drachman D, Rosenfield K, Jang IK. Catheterization and Cardiovascular 72(1):116-20. FI: 2.363 (Q2) What Is The Optimal Anticoagulation Level With Argatroban During Percutaneous Coronary Intervention Cruz-González I, Sánchez-Ledesma M, Osakabe M, Watanabe H, Baron S, Healy JL Yeh RW, Jang IK. Blood Coagulation & Fibrinolysis 19(5):401-4. FI: 1.246 (Q4)
|
